In Brief: Vagistat-1
This article was originally published in The Tan Sheet
Vagistat-1: 15-second teaser TV ad positions Bristol-Myers Squibb's one-day OTC vaginal yeast infection treatment (tioconazole) as the "future" of the category: "the future is one." All major retailers now have the product on shelves. New York City-based BDDP, Vagistat-1's agency of record, said longer spots will begin airing May 14...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC